A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting.

ABSTRACT:

Background

Urine drug screening (UDS) is commonly used as part of treatment for opioid use disorder (OUD), including treatment with buprenorphine-naloxone for OUD in a primary care setting. Very little is known about the value of UDS, the optimum screening frequency in general, or its specific use for buprenorphine treatment in primary care. To address this question, we thought that in a stable population receiving buprenorphine-naloxone in the primary care setting it would be useful to know how often UDS yielded expected and unexpected results.

Methods

We present a descriptive analysis of UDS results in patients treated with buprenorphine-naloxone for OUD in a primary care setting over a two-year period. An unexpected test result is: 1. A negative test for buprenorphine and

SUBMITTER: Sobel HG 

PROVIDER: S-EPMC8482571 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature